FDA Accused of Laxity Over Posting of Clinical Trial Results

North America

Feb 27

Written By Justin Mendoza

Read in Bloomberg Law

Eli Lilly & Co. Price Drop

FDA is petitioned to boost enforcement of trial sponsors that fail to register studies or report results